User:Dameister22/sandbox

This is a user sandbox of Dameister22. You can use it for testing or practicing edits.
This is not the sandbox where you should draft your assigned article for a dashboard.wikiedu.org course.
To find the right sandbox for your assignment, visit your Dashboard course page and follow the Sandbox Draft link for your assigned article in the My Articles section.

Get Help

Links: The chain button allows you to link your text. Highlight the word, and push the button. VisualEditor will automatically suggest related Wikipedia articles for that word or phrase. This is a great way to connect your article to more Wikipedia content. You only have to link important words once, usually during the first time they appear. If you want to link to pages outside of Wikipedia (for an "external links" section, for example) click on the "External link" tab.

Cite: The citation tool in VisualEditor helps format your citations. You can simply paste a DOI or URL, and the VisualEditor will try to sort out all of the fields you need. Be sure to review it, however, and apply missing fields manually (if you know them). You can also add books, journals, news, and websites manually. That opens up a quick guide for inputting your citations. Finally, you can click the "re-use" tab if you've already added a source and just want to cite it again.

Bullets: To add bullet points or a numbered list, click here.

Insert: This tab lets you add media, images, or tables.

Potential addition for "Research Directions" section

A systematic review showed that microRNA could provide a relatively quick and easily accessed method for detection of Alzheimer's Disorder. Further research is required to classify miRNA as well as isolate specific miRNA combinations associated with AD.^[1] Dameister22 Dameister22 (talk) 19:48, 8 March 2016 (UTC)

Potential addition to the "Medication" section

A systematic review has found that Idalopirdine, in conjuction with donepezil had a positive effect on cognitive functioning in patients with moderate Alzheimers.^[2] Dameister22 (talk) 19:48, 8 March 2016 (UTC)

Notes

^ Hu, Yong-Bo; Li, Chun-Bo; Song, Ning; Zou, Yang; Chen, Sheng-Di; Ren, Ru-Jing; Wang, Gang (2016-02-09). "Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis". Frontiers in Aging Neuroscience. 8. doi:10.3389/fnagi.2016.00013. ISSN 1663-4365. PMC 4746262. PMID 26903857.{{cite journal}}: CS1 maint: unflagged free DOI (link)
^ Wilkinson, David; Windfeld, Kristian; Colding-Jørgensen, Eskild (2014-11-01). "Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial". The Lancet. Neurology. 13 (11): 1092–1099. doi:10.1016/S1474-4422(14)70198-X. ISSN 1474-4465. PMID 25297016.

[1] Hu, Yong-Bo; Li, Chun-Bo; Song, Ning; Zou, Yang; Chen, Sheng-Di; Ren, Ru-Jing; Wang, Gang (2016-02-09). "Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis". Frontiers in Aging Neuroscience. 8. doi:10.3389/fnagi.2016.00013. ISSN 1663-4365. PMC 4746262. PMID 26903857.{{cite journal}}: CS1 maint: unflagged free DOI (link)

[2] Wilkinson, David; Windfeld, Kristian; Colding-Jørgensen, Eskild (2014-11-01). "Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial". The Lancet. Neurology. 13 (11): 1092–1099. doi:10.1016/S1474-4422(14)70198-X. ISSN 1474-4465. PMID 25297016.

[1]

[2]